China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ)
CNY 43.18
(0.61%)
CNY 43.18
(0.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 24.73 Billion | 18.07 Billion | 15.31 Billion | 13.63 Billion | 14.7 Billion | 13.42 Billion |
| Cost of Revenue | 11.72 Billion | 8.31 Billion | 6.17 Billion | 5.11 Billion | 4.83 Billion | 4.16 Billion |
| Gross Profit | 13.01 Billion | 9.76 Billion | 9.14 Billion | 8.51 Billion | 9.87 Billion | 9.26 Billion |
| Operating Expenses | 9.41 Billion | 6.71 Billion | 6.49 Billion | 6.33 Billion | 7.9 Billion | 7.55 Billion |
| Selling, General and Administrative Expenses | 8.33 Billion | 5.33 Billion | 5.27 Billion | 5.25 Billion | 6.78 Billion | 6.64 Billion |
| Research and Development Expenses | 714.5 Million | 593.94 Million | 560.2 Million | 459.84 Million | 441.87 Million | 355.84 Million |
| Other Expenses | - | 792.47 Million | 662.24 Million | 625.09 Million | 678.32 Million | 15.4 Million |
| Cost and Expenses | 20.98 Billion | 15.03 Billion | 12.66 Billion | 11.45 Billion | 12.73 Billion | 11.71 Billion |
| Operating Income | 3.75 Billion | 2.94 Billion | 2.45 Billion | 2.07 Billion | 2.52 Billion | 1.7 Billion |
| Interest Expense | 70.94 Million | 21.22 Million | 13.26 Million | 5.08 Million | 4.4 Million | 25.83 Million |
| Income Tax Expense | 580.97 Million | 466.42 Million | 348.21 Million | 441.88 Million | 429.54 Million | 244 Million |
| Earnings before Tax | 3.75 Billion | 2.96 Billion | 2.42 Billion | 2.05 Billion | 2.56 Billion | 1.71 Billion |
| Net Income | 2.85 Billion | 2.44 Billion | 2.05 Billion | 1.59 Billion | 2.11 Billion | 1.43 Billion |
| Earnings Per Share Basic | 2.23 | 2.50 | 2.10 | 1.63 | 2.14 | 1.46 |
| Earnings Per Share Diluted | 2.23 | 2.50 | 2.10 | 1.63 | 2.14 | 1.46 |
| Weighted Average Shares Outstanding | 1.27 Billion | 978.9 Million | 978.9 Million | 978.9 Million | 978.9 Million | 978.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.27 Billion | 978.9 Million | 978.9 Million | 978.9 Million | 978.9 Million | 980.87 Million |
| Gross Margin | 0.53 | 0.54 | 0.60 | 0.62 | 0.67 | 0.69 |
| EBIT Margin | 0.19 | 0.20 | 0.21 | 0.20 | 0.21 | 0.16 |
| Profit Margin | 0.12 | 0.14 | 0.13 | 0.12 | 0.14 | 0.11 |
| EBITDA | 4.68 Billion | 3.55 Billion | 2.98 Billion | 2.49 Billion | 2.93 Billion | 2.12 Billion |
| Earnings Before Tax Margin | 0.15 | 0.16 | 0.16 | 0.15 | 0.17 | 0.13 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 5.63 Billion | 6.73 Billion | 7.21 Billion | 24.46 Billion | 6.04 Billion | 5.46 Billion |
| Cost of Revenue | 2.79 Billion | 3.23 Billion | 3.39 Billion | 11.85 Billion | 2.67 Billion | 2.68 Billion |
| Gross Profit | 2.84 Billion | 3.5 Billion | 3.82 Billion | 12.6 Billion | 3.37 Billion | 2.77 Billion |
| Operating Expenses | 2 Billion | 2.26 Billion | 2.09 Billion | 9.08 Billion | 2.97 Billion | 1.99 Billion |
| Selling, General and Administrative Expenses | 3.07 Billion | 2.06 Billion | 1.92 Billion | - | 2.61 Billion | 2.36 Billion |
| Research and Development Expenses | 185.71 Million | 168.39 Million | 137.41 Million | - | 237.1 Million | 163.23 Million |
| Other Expenses | -1.25 Billion | -33.99 Million | -38.23 Million | -108.17 Million | -129.95 Million | 6.59 Million |
| Cost and Expenses | 4.79 Billion | 5.49 Billion | 5.49 Billion | 20.94 Billion | 5.65 Billion | 4.68 Billion |
| Operating Income | 739.38 Million | 1.23 Billion | 1.72 Billion | 3.52 Billion | 395.46 Million | 751.25 Million |
| Interest Expense | 22.33 Million | 22.29 Million | 20.82 Million | 80.78 Million | 28.49 Million | 25.24 Million |
| Income Tax Expense | 157.78 Million | 232.12 Million | 349.97 Million | 580.97 Million | 26.43 Million | 118.97 Million |
| Earnings before Tax | 825.44 Million | 1.36 Billion | 1.8 Billion | 3.74 Billion | 504.75 Million | 754.29 Million |
| Net Income | 561.47 Million | 1.03 Billion | 1.36 Billion | 2.85 Billion | 450.33 Million | 525.47 Million |
| Earnings Per Share Basic | 0.44 | 0.81 | 1.39 | - | 0.46 | 0.54 |
| Earnings Per Share Diluted | 0.44 | 0.81 | 1.39 | - | 0.46 | 0.54 |
| Weighted Average Shares Outstanding | 1.27 Billion | 1.27 Billion | 978.9 Million | 978.9 Million | 978.9 Million | 978.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.27 Billion | 1.27 Billion | 978.9 Million | 978.9 Million | 978.9 Million | 978.73 Million |
| Gross Margin | 0.50 | 0.52 | 0.53 | 0.52 | 0.56 | 0.51 |
| EBIT Margin | 0.15 | 0.22 | 0.26 | - | 0.10 | 0.15 |
| Profit Margin | 0.10 | 0.15 | 0.19 | 0.12 | 0.07 | 0.10 |
| EBITDA | 847.78 Million | 1.46 Billion | 1.88 Billion | - | 621.1 Million | 825.3 Million |
| Earnings Before Tax Margin | 0.13 | 0.18 | 0.24 | 0.14 | 0.07 | 0.14 |
4720
039200
600889
SCCO
002168
010130